Today: 28 April 2026

Barrick Mining Corporation (NYSE: B, TSX: ABX) Stock Soars on North American Gold IPO Plan – Latest News, Analyst Targets and 2025–2030 Outlook

Barrick Mining Corporation (NYSE: B, TSX: ABX) Stock Soars on North American Gold IPO Plan – Latest News, Analyst Targets and 2025–2030 Outlook

Barrick Mining shares jumped to decade highs after the company said it will explore an IPO for a new unit holding its top North American gold assets. The stock closed near $42.33 on December 1, boosted by record gold prices and activist pressure from Elliott Management. Barrick reported record Q3 earnings, raised its dividend, and expanded its buyback program.
2 December 2025
···
Toronto-Dominion Bank Stock (TD): December 2025 Outlook Ahead of Q4 Earnings, AML Overhang and Dividend Growth

Toronto-Dominion Bank Stock (TD): December 2025 Outlook Ahead of Q4 Earnings, AML Overhang and Dividend Growth

Toronto-Dominion Bank shares closed at C$117.15 on Dec. 1, near record highs and up nearly 49% year-to-date. Investors await Q4 2025 earnings on Dec. 4, while the stock trades at a P/E of 9.76 and a dividend yield of about 3.6%. Analysts give a “Moderate Buy” rating, with price targets close to current levels. The bank is still contending with the impact of a US$3 billion AML settlement in the U.S.
2 December 2025
·
Equinix (EQIX) Stock: SEC Probe Ends, AI Supercomputer Deal and 2026 Price Targets – December 1, 2025 Outlook

Equinix (EQIX) Stock: SEC Probe Ends, AI Supercomputer Deal and 2026 Price Targets – December 1, 2025 Outlook

Equinix shares closed at $733.28 on December 1, 2025, down 2.66% for the day and 26% below last year’s high. The stock has underperformed both the S&P 500 and data-center peers despite record Q3 bookings and 11% AFFO growth. Most major analysts maintain a “Strong Buy” rating with price targets 25–30% above current levels.
2 December 2025
···
Cintas Stock (CTAS) on December 1, 2025: Price, Q1 2026 Earnings Beat, Dividend Hike and 2026–2028 Forecast

Cintas Stock (CTAS) on December 1, 2025: Price, Q1 2026 Earnings Beat, Dividend Hike and 2026–2028 Forecast

Cintas shares closed at $185.43 on December 1, 2025, down nearly 19% from the June high of $229.24 and just above the 52-week low. The company reported Q1 FY 2026 revenue of $2.72 billion, up 8.7% year over year, and net income of $491.1 million. Cintas announced a new $1 billion buyback and extended its dividend growth streak. The stock trades at about 41–42 times trailing earnings.
2 December 2025
····
Ecolab (ECL) Stock Outlook on December 1, 2025: Earnings Momentum, AI-Driven Water Tech and Wall Street Forecasts

Ecolab (ECL) Stock Outlook on December 1, 2025: Earnings Momentum, AI-Driven Water Tech and Wall Street Forecasts

Ecolab shares traded near 52-week highs on December 1, 2025, closing at $272.86 after reporting Q3 earnings with 13% EPS growth and revenue of $4.17 billion. The company launched new AI and water-focused products and maintains a market cap near $78 billion. Ecolab’s dividend yield stands at about 0.9–1.0%. The stock outperformed the broader materials sector and key peers over the past year.
2 December 2025
···
U.S. Bancorp (USB) Stock on December 1, 2025: Q3 Earnings Beat, 4%+ Dividend and 2026 Forecasts

U.S. Bancorp (USB) Stock on December 1, 2025: Q3 Earnings Beat, 4%+ Dividend and 2026 Forecasts

U.S. Bancorp closed at $49.41 on December 1, 2025, after reporting record Q3 revenue of $7.33 billion and net income of $2 billion, both above analyst expectations. The stock yields about 4.2% and has outperformed regional bank peers over the past three months. Shares remain below year-ago levels and face ongoing scrutiny over insider sales and regulatory risks.
2 December 2025
····
General Dynamics Stock (GD) in December 2025: Earnings Beats, Massive Backlog and a New Legal Challenge

General Dynamics Stock (GD) in December 2025: Earnings Beats, Massive Backlog and a New Legal Challenge

General Dynamics shares closed at $332.38 on December 1, down 2.71% but up 26% year-to-date. The company reported three straight quarters of double-digit earnings growth in 2025 and ended Q2 with a record $88.7 billion backlog. Shares remain about 7.8% below the October 24 high. A new legal issue has emerged as Wall Street interest climbs.
2 December 2025
··
Interstellar Comet 3I/ATLAS Makes Closest Approach to Earth on December 19, 2025 — How to See It and Why It Matters

Interstellar Comet 3I/ATLAS Makes Closest Approach to Earth on December 19, 2025 — How to See It and Why It Matters

Interstellar comet 3I/ATLAS will pass Earth at about 170 million miles on December 19, 2025, nearly twice the distance to the Sun. Discovered in July by the ATLAS telescope in Chile, the comet is moving too fast to be bound to the Sun. NASA confirms there is no risk to Earth. The object is the third confirmed interstellar visitor after 1I/ʻOumuamua and 2I/Borisov.
2 December 2025
·
December 2025 Night Sky Guide: Supermoon, Geminids and Interstellar Comet 3I/ATLAS Light Up the Month

December 2025 Night Sky Guide: Supermoon, Geminids and Interstellar Comet 3I/ATLAS Light Up the Month

A powerful X-class solar flare erupted on November 30, 2025, raising hopes for auroras near the winter solstice. NASA and major observatories have released new forecasts for December, highlighting the final supermoon on December 4 and the Geminid meteor shower peak on December 13–14. Mercury reaches its best morning view on December 7. An interstellar comet will make its closest approach on December 19.
2 December 2025
·
Starbucks Stock (SBUX) on December 1, 2025: NYC Settlement, Union Strike and Wall Street’s 2026 Forecast

Starbucks Stock (SBUX) on December 1, 2025: NYC Settlement, Union Strike and Wall Street’s 2026 Forecast

Starbucks shares fell 2.5% to $84.91 on December 1 after agreeing to a $38.9 million New York City settlement over alleged violations of worker scheduling laws. The drop comes amid a nationwide union strike and split analyst views on the company’s outlook. Starbucks remains up 4.2% year-to-date but trades well below its 2021 peak.
2 December 2025
··
Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

Bristol-Myers Squibb (BMY) Stock Today: Lawsuit Shock, Breyanzi Momentum and 2026 Forecast

A U.S. federal judge allowed a $6.7 billion lawsuit against Bristol-Myers Squibb over its 2019 Celgene acquisition to proceed, rejecting the company’s motion to dismiss key claims. BMY shares closed at $49.18 on December 1, up 7–8% over five days, but remain down for the year. The company’s annual dividend yield is about 5%. New cell therapy approvals and strong ASH 2025 hematology data also drew investor attention.
2 December 2025
·
Newmont Stock Soars in 2025 as Gold Hits Records: Is NEM Still a Buy After UBS Lifts Target to $125?

Newmont Stock Soars in 2025 as Gold Hits Records: Is NEM Still a Buy After UBS Lifts Target to $125?

Newmont stock closed at $91.83 on December 1, 2025, more than doubling year-to-date after a 12% jump in November. UBS raised its price target to $125, citing strong gold prices and Newmont’s record free cash flow. The company posted Q3 net income of $1.8 billion and revenue of $5.52 billion, both beating estimates. Newmont has rapidly reduced debt and increased share buybacks.
2 December 2025
·
CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health Stock in December 2025: Price, Forecast, Dividend and Whether the Rally Still Has Room to Run

CVS Health shares closed at $79.10 on December 1, 2025, down 1.6% and about 7% below their 52-week high. The stock is up nearly 79% year-to-date. Q3 revenue rose 7.8% to $102.9 billion, with adjusted EPS of $1.60 but a GAAP loss per share of –$3.13 due to a $5.7 billion non-cash goodwill impairment. CVS’s trailing P/E ratio spiked above 200 from the one-time charge.
2 December 2025
··
CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

CME Group (CME) Stock: Outage Fallout, Record Volumes and 2026 Price Targets Explained

CME Group halted trading for about 10 hours on November 28 after a cooling failure at a CyrusOne data center in Illinois, disrupting global futures and options markets. Shares closed at $279, down 0.9%, with a market cap over $100 billion. CME stock is up about 21% year-to-date, but some analysts warn it may be overvalued by up to 40%. The company paid $10.80 per share in dividends over the past year.
2 December 2025
·
Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War

Parker-Hannifin (PH) Stock Outlook December 2025: Aerospace Strength, $9.25B Filtration Deal and a Valuation Tug of War

Parker-Hannifin closed December 1, 2025, at about $856 per share, with a $109 billion market cap. The stock is up roughly 36% year-to-date, beating the S&P 500. Growth is driven by strong aerospace results and the $9.25 billion Filtration Group acquisition. Some models now estimate PH is overvalued by about 30%, though most analysts remain positive.
1 December 2025
·
1 … 1,398 1,399 1,400 1,401 1,402 … 1,875

Stock Market Today

  • Nayax (TASE:NYAX) Shows Strong Gains but Valuation Seen as Overvalued at ₪166.49
    April 27, 2026, 6:52 PM EDT. Nayax shares (TASE:NYAX) surged 14.37% in the past 30 days, adding to a 20.12% gain year-to-date and a 215.30% rise over three years. Despite this momentum, analysts value it at ₪166.49, about 19% below the current price of ₪198.2, suggesting the stock is overvalued. Analyst price targets vary widely from ₪119.65 to ₪213.33, reflecting differing views on growth potential and risks. Key concerns include regulatory tightening on payments data and competitive pressure on margins. Investors should weigh these factors carefully and consider underlying financials before committing.

Latest article

Wall Street’s Fear Gauge Flashes An Odd Signal As Stocks Hit Records

Wall Street’s Fear Gauge Flashes An Odd Signal As Stocks Hit Records

28 April 2026
The VIX spot price fell 3.69% to 18.02 on Monday as the S&P 500 and Nasdaq closed at record highs, but VIX futures for May and June stayed above 20. Options data showed investors continued to pay for future volatility amid megacap earnings, Fed policy, and Middle East tensions. The Dow slipped 0.13%, while the S&P 500 rose 0.12% and the Nasdaq gained 0.20%.
Go toTop